NWRD08 administered by electroporation

BIOLOGICAL2 trials

Sponsors

Newish Technology (Beijing) Co., Ltd., Newish Biotech (Wuxi) Co., Ltd.

Conditions

High-grade Squamous Intraepithelial Lesion (HSIL)

Phase 1

NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

CompletedNCT06276101

Newish Technology (Beijing) Co., Ltd.High-grade Squamous Intraepithelial Lesion (HSIL)

Start: 2024-05-07End: 2025-12-30Updated: 2026-06-25

Phase 2

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

RecruitingNCT07175662

Newish Biotech (Wuxi) Co., Ltd.High-grade Squamous Intraepithelial Lesion (HSIL)

Start: 2025-11-11End: 2027-08-30Target: 150Updated: 2026-02-17